I think things will liven up when they announce the trial conditions and start date. I am guessing the trial will be around 385 patients based on a 95% confidence level. If it is, i think the market will look at it very favourably, especially if we get $25k reimbursement and continued sales post final operation. Continued sales is extremely good as a 1 year wait from last operation to fda approval with nothing in between would see a decent drift in share price.
New 6-month low, or 24-month low?, page-8
-
- There are more pages in this discussion • 64 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.84 |
Change
-0.165(1.65%) |
Mkt cap ! $209.4M | |||
| Open | High | Low | Value | Volume |
| $10.00 | $10.00 | $9.65 | $55.69K | 5.666K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 366 | $9.77 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.90 | 85 | 1 |
View Market Depth
| Last trade - 15.53pm 12/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |